Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
02 Hydroxychloroquine myopathy: cardiac and skeletal muscle toxicityLupus science & medicine, 2021-04, Vol.8 (Suppl 1), p.A1-A2 [Peer Reviewed Journal]Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2021 Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;EISSN: 2053-8790 ;DOI: 10.1136/lupus-2021-la.2Full text available |
|
2 |
Material Type: Article
|
03 Low dose aspirin in aPL-positive patients: Are we treating the patient or the doctor?Lupus science & medicine, 2021-04, Vol.8 (Suppl 1), p.A2-A2 [Peer Reviewed Journal]Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2021 Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;EISSN: 2053-8790 ;DOI: 10.1136/lupus-2021-la.3Full text available |
|
3 |
Material Type: Article
|
04 Biology of interferons in SLE: insights from longitudinal data analysisLupus science & medicine, 2021-04, Vol.8 (Suppl 1), p.A2-A3 [Peer Reviewed Journal]Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2021 Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;EISSN: 2053-8790 ;DOI: 10.1136/lupus-2021-la.4Full text available |
|
4 |
Material Type: Article
|
06 Microangiopathy in SLE: a diagnostic and therapeutic challengeLupus science & medicine, 2020-09, Vol.7 (Suppl 2), p.A4-A4 [Peer Reviewed Journal]Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ. ;EISSN: 2053-8790 ;DOI: 10.1136/lupus-2020-la.6Digital Resources/Online E-Resources |
|
5 |
Material Type: Article
|
1 H‐Magnetic Resonance Spectroscopy for Quantifying Myocardial Lipid Content in Humans With the Cardiometabolic SyndromeThe journal of clinical hypertension (Greenwich, Conn.), 2009-09, Vol.11 (9), p.528-532 [Peer Reviewed Journal]ISSN: 1524-6175 ;EISSN: 1751-7176 ;DOI: 10.1111/j.1559-4572.2009.00061.xFull text available |
|
6 |
Material Type: Article
|
10 most common toxicoses in dogsVeterinary medicine (1985), 2006-03, Vol.101 (3), p.142 [Peer Reviewed Journal]COPYRIGHT 2006 Intellisphere, LLC ;Copyright Medical Economics Inc. Mar 2006 ;ISSN: 8750-7943 ;EISSN: 1939-1919Digital Resources/Online E-Resources |
|
7 |
Material Type: Article
|
10 simple but essential testsVeterinary medicine (1985), 2008-06, Vol.103 (6), p.S10 [Peer Reviewed Journal]COPYRIGHT 2008 Intellisphere, LLC ;Copyright Advanstar Communications, Inc. Jun 2008 ;ISSN: 8750-7943 ;EISSN: 1939-1919Full text available |
|
8 |
Material Type: Article
|
100 YEARS OF VITAMIN D: Supraphysiological doses of vitamin D changes brainwave activity patterns in ratsEndocrine Connections, 2022-03, Vol.11 (3) [Peer Reviewed Journal]The authors 2022 The authors ;ISSN: 2049-3614 ;EISSN: 2049-3614 ;DOI: 10.1530/EC-21-0457 ;PMID: 35148281Full text available |
|
9 |
Material Type: Article
|
105 Non-traditional risk factors predict cardiovascular disease and contribute to disparities in a population-based cohort with systemic lupus erythematosusLupus science & medicine, 2024-05, Vol.11 (Suppl 2), p.A5-A8 [Peer Reviewed Journal]Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2024 Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;EISSN: 2053-8790 ;DOI: 10.1136/lupus-2023-lupus21century.5Full text available |
|
10 |
Material Type: Article
|
11 guidelines for conservatively treating chronic kidney diseaseVeterinary medicine (1985), 2007-12, Vol.102 (12), p.788-790 [Peer Reviewed Journal]Copyright Advanstar Communications, Inc. Dec 2007 ;ISSN: 8750-7943 ;EISSN: 1939-1919Full text available |
|
11 |
Material Type: Article
|
11 guidelines for conservatively treating chronic kidney disease: you can prolong and improve the quality of life in dogs and cats suffering from this reduction in kidney function by monitoring and treating key parameters and signsVeterinary medicine (1985), 2007-12, Vol.102 (12), p.788 [Peer Reviewed Journal]COPYRIGHT 2007 Intellisphere, LLC ;ISSN: 8750-7943 ;EISSN: 1939-1919Full text available |
|
12 |
Material Type: Article
|
1101 Use of popular opinion leader models to disseminate information about clinical trials to people of color with lupus in two U.S. citiesLupus science & medicine, 2021-11, Vol.8 (Suppl 2), p.A29-A29 [Peer Reviewed Journal]Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2021 Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;EISSN: 2053-8790 ;DOI: 10.1136/lupus-2021-lupus21century.44Full text available |
|
13 |
Material Type: Article
|
1105 Response Gene to Complement-32 expression is upregulated in the kidney and promotes renal fibrosis in lupus nephritisLupus science & medicine, 2022-12, Vol.9 (Suppl 3), p.A71-A72 [Peer Reviewed Journal]Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2022 Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;EISSN: 2053-8790 ;DOI: 10.1136/lupus-2022-lupus21century.70Full text available |
|
14 |
Material Type: Article
|
1106 Stability of novel urinary biomarkers used for lupusLupus science & medicine, 2022-12, Vol.9 (Suppl 3), p.A72-A73 [Peer Reviewed Journal]Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2022 Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;EISSN: 2053-8790 ;DOI: 10.1136/lupus-2022-lupus21century.71Full text available |
|
15 |
Material Type: Article
|
1114 Parenchymal INFγ Response Regulates Murine Lupus Nephritis in a PD-L1 Independent FashionLupus science & medicine, 2022-12, Vol.9 (Suppl 3), p.A79-A80 [Peer Reviewed Journal]Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2022 Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;EISSN: 2053-8790 ;DOI: 10.1136/lupus-2022-lupus21century.79Full text available |
|
16 |
Material Type: Article
|
1114 Trajectory of damage accrual in systemic lupus erythematosus based on ethnicity, socioeconomic factors and comorbiditiesLupus science & medicine, 2021-11, Vol.8 (Suppl 2), p.A40-A40 [Peer Reviewed Journal]Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2021 Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;EISSN: 2053-8790 ;DOI: 10.1136/lupus-2021-lupus21century.57Full text available |
|
17 |
Material Type: Article
|
1115 RAIL biomarkers capture response to induction therapy in pediatric patients during induction therapyLupus science & medicine, 2022-12, Vol.9 (Suppl 3), p.A80-A81 [Peer Reviewed Journal]Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2022 Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;EISSN: 2053-8790 ;DOI: 10.1136/lupus-2022-lupus21century.80Full text available |
|
18 |
Material Type: Article
|
1115 The type 1 & 2 SLE model: the perspective of patients and rheumatologistsLupus science & medicine, 2021-11, Vol.8 (Suppl 2), p.A40-A41 [Peer Reviewed Journal]Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2021 Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;EISSN: 2053-8790 ;DOI: 10.1136/lupus-2021-lupus21century.58Full text available |
|
19 |
Material Type: Article
|
12 WEEKS OF PROGRESSIVE RESISTANCE TRAINING ON POSTURAL BALANCE AND CONCERNS ABOUT FALLING IN OLDER ADULTS: RANDOMIZED CONTROLLED TRIALMotricidade, 2021-12, Vol.17 (4), p.1-21 [Peer Reviewed Journal]2021. This work is published under https://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. ;ISSN: 1646-107X ;EISSN: 2182-2972 ;DOI: 10.6063/motricidade.24977Full text available |
|
20 |
Material Type: Article
|
12 Management of lupus skin manifestationsLupus science & medicine, 2022-04, Vol.9 (Suppl 1), p.A6-A7 [Peer Reviewed Journal]Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2022 Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;EISSN: 2053-8790 ;DOI: 10.1136/lupus-2022-la.12Full text available |